查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722974

2025 年至 2033 年放射性皮肤炎市场规模、份额、趋势及预测（按产品、配销通路和地区）

Radiodermatitis Market Size, Share, Trends and Forecast by Product, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球放射性皮肤炎市场规模价值 5.1478 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 6.6802 亿美元，2025 年至 2033 年的复合年增长率为 2.94%。亚太地区目前占据市场主导地位，到 2024 年其市占率将超过 34%。放射性皮肤炎的市场份额正在扩大，这得益于全球癌症患者数量的增加、治疗方式的进步以及对非侵入性、以患者为中心的治疗的需求不断增长。

放射性皮肤炎或放射性皮肤炎是指因治疗癌症的放射疗法而引起的皮肤病。它通常作为癌症治疗期间的副作用出现，或发生在乳腺癌、肺癌、皮肤癌、颈部癌、头部癌或会阴癌患者接受介入放射学治疗后，其中皮肤是治疗靶区的一部分。一些常用的治疗放射性皮肤炎的产品包括外用抗生素、皮质类固醇、亲水性乳膏、水凝胶和水胶体敷料、硅胶涂层敷料、银叶敷料、口服止痛药和抗发炎药物。近年来，放射性皮肤炎治疗越来越受到人们的关注，因为它有助于减轻不适、减轻疼痛、防止中断正在进行的治疗，同时提高患者的整体生活品质。

放射性皮肤炎市场趋势：

癌症的广泛流行和放射疗法作为治疗选择的日益普及是推动市场成长的主要因素。除此之外，全球老年人口的不断增加以及对抗放射治疗不良副作用的需求不断增长，增加了对放射性皮肤炎治疗的需求。此外，许多管理机构和非管理机构正在采取积极倡议，传播对放射性皮肤炎治疗和管理产品的意识。这与公共和私人对生命科学领域正在进行的研究和开发 (R&D) 活动的投资不断增加相结合，催化了市场的成长。此外，领先的企业正专注于开发创新的产品变体，以扩大其产品组合併获得竞争优势。此外，临床试验数量的增加、政府的优惠政策、消费者支出能力的提高、医疗保健基础设施的改善以及仿製药的易于获得也是创造积极市场前景的其他一些因素。

本报告回答的关键问题

  • 放射性皮肤炎市场有多大？放射性皮肤炎市场的未来前景如何？
  • 推动放射性皮肤炎市场发展的关键因素有哪些？
  • 哪个地区占据放射性皮肤炎最大的市占率？
  • 全球放射性皮肤炎市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球放射性皮肤炎市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 外用
    • 关键部分
      • 皮质类固醇
      • 亲水性乳膏
      • 抗生素
      • 其他的
  • 口服
  • 敷料
    • 关键部分
      • 水凝胶和水胶体敷料
      • 无刺痛阻隔膜
      • 蜂蜜浸渍纱布
      • 硅胶涂层敷料
      • 其他的

第七章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA SpA
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112025A5638

The global radiodermatitis market size was valued at USD 514.78 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 668.02 Million by 2033, exhibiting a CAGR of 2.94% from 2025-2033. Asia Pacific currently dominates the market, holding a market share of over 34% in 2024. The radiodermatitis market share is expanding, driven by the increasing numbers of cancer patients worldwide, heightened advancements in treatment modalities, and rising demand for the non-invasive, patient-centered treatments.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life.

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

Breakup by Product:

  • Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Antibiotics
  • Others
  • Oral
  • Dressings
  • Hydrogel and Hydrocolloid Dressings
  • No Sting Barrier Film
  • Honey Impregnated Gauze
  • Silicone Coated Dressings
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report

  • 1.How big is the radiodermatitis market?
  • 2.What is the future outlook of radiodermatitis market?
  • 3.What are the key factors driving the radiodermatitis market?
  • 4.Which region accounts for the largest radiodermatitis market share?
  • 5.Which are the leading companies in the global radiodermatitis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiodermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11 Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2024
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players